News and Announcements
Proteomics Gaining Strong Traction in Analytical Services
- Published May 20, 2016 1:27PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
20th May 2016, ASX Announcement
- PILL has generated monthly revenues of $100,000 in each of March and April (a 60% uplift on the previous monthly average).
- Several recent contract wins underscore ongoing activity.
- Growth driven by biosimilars (generic protein drug) market as the sector seeks to replicate the multiple billion dollar blockbuster biopharmaceutical drugs that are coming off patent.
- PILL has one of the few global ISO 17025 laboratories accredited to accurately analyse the make-up of biosimilar drugs as being like-for-like with the brand-name drugs they seek to replace.
- Present growth substantiates business model as PILL seeks to become cash flow positive.
Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to provide the following update on the growth of its analytical services operations.
PILL’s analytical services generate a regular ongoing revenue stream by providing a fee-for-service offering in proteomics, protein characterisation, biosimilars and biomarker diversity.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
